ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AGL Angle Plc

12.25
-0.25 (-2.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -2.00% 12.25 12.00 12.50 12.50 12.25 12.50 553,192 13:40:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Business Services, Nec 1.04M -21.69M -0.0832 -1.47 31.92M
Angle Plc is listed in the Business Services sector of the London Stock Exchange with ticker AGL. The last closing price for Angle was 12.50p. Over the last year, Angle shares have traded in a share price range of 9.125p to 37.50p.

Angle currently has 260,580,547 shares in issue. The market capitalisation of Angle is £31.92 million. Angle has a price to earnings ratio (PE ratio) of -1.47.

Angle Share Discussion Threads

Showing 19901 to 19919 of 32500 messages
Chat Pages: Latest  808  807  806  805  804  803  802  801  800  799  798  797  Older
DateSubjectAuthorDiscuss
18/10/2022
10:34
i suggest everyone email investor relations at AGL ...Give them your thoughts !!!
amaretto1
18/10/2022
10:30
Filtered for being a ignorant PIG !!!!
amaretto1
18/10/2022
10:24
Oh dear somenposters looking like fools again after that RNs. The fact they are already concerned about the cash runway shows they are not making progress very fast and are now likely to run out of cash yet again before getting anywhere near break even .

For this to turn they need to sign big deals with numbers that the city can use to see how long they have to wait before breaking even.

Who would have thought after FDA approval they are back in the 40's just shows what a mess AN has made of running the company . Great scientist poor CEO imo .

bones698
18/10/2022
10:23
So if there is a distressed seller, why are the company’s broker not in contact with them in order to do a clean out transaction to place the stock in firm institutional hands?
henley2
18/10/2022
10:20
I'm still waiting for management to tell me when to buy, I stopped buying when they told me they didn't want shareholders making money around the 150p level
che7win
18/10/2022
10:16
Just like it didnt record the last time it dropped this low? Muppet
zeus19
18/10/2022
10:15
Yawn, youre a broken record
zeus19
18/10/2022
10:12
74Tom, get a grip and stop running around the playground screaming. There are a number of distressed sellers in the market and they need to turn their assets liquid. You're imagination is running wild. No amount of good news will turn the share price until they have exhausted their sales.

I've just bought 15000 and it went through as a sell.

hairballradical
18/10/2022
10:12
Heading further south, FFS!
vatnabrekk
18/10/2022
10:10
At 49.6p the enterprise value (market cap less cash) is less than $100m. And it has now gone below that. Totally ripe for a takeover offer at the moment.
sicilian_kan
18/10/2022
10:09
The mkt madness continues - at this rate I'm going to need to top up
spaceparallax
18/10/2022
10:09
74Tom,

are you suggesting that the day after tax credits removal are announced you close down a whole operation without discussion with the team in Canada and put everyone out onto the street?

These things take months to sort out, no doubt the govt would have been involved for discussions on potential R&D tax breaks over there. So actually this has been done phenomenally quickly and the board deserve great praise.

Same R&D functions being undertaken, significant cash savings and no doubt greater control over which R&D is done and how that money was being spent.

Well done to the board.

hairballradical
18/10/2022
10:06
Relentless selling after a 'good RNS'. Maybe the '3 BIG COMPANIES' they talked to have walked away and not interested.

Be prepared to receive news distribution agreement in Uganda. What an achievement!

deanmatlazin
18/10/2022
10:04
Yes it was mentioned
amaretto1
18/10/2022
10:04
And I didn't say it shouldn't be RNS'd, just that it shouldn't be released on it's own. The interims were released 12 days ago and no mention was made of this change, that's the problem here and why the share price is tumbling.
74tom
18/10/2022
10:01
Bagpuss, this was just posted on LSE;

"Concerning announcement. Suggests lack of grip from Board and CEO.

These tax credit changes were published in July.

So why wasn’t this flagged at the Interims? Nothing new has happened since the interims for the Board to consider this change - unless they are becoming increasingly concerned on cash.

Seems to me the CEO doesn't have a proper strategy - except for spray and pray."

74tom
18/10/2022
09:40
Bagpuss, as I have stated before I’m a long term shareholder here.
When Jupiter dumped their position a few years ago and the share price collapsed to 40p,
FDA approval had not been achieved, unlike now. I wish I did have a short SB, but alas not. AN talks a great deal about multi-billion dollar market opportunities, is He and the current Board the right people to achieve it? Market says NO, hence the need for a change in personnel, starting with a refresh of the Board.

henley2
18/10/2022
09:39
The closure had to be RNSd. Otherwise news of redundancies would have appeared anyway. Best to explain before.
purchaseatthetop
18/10/2022
09:31
I strongly suggest ignoring serial rampers like AMARETTO and PURCHASE. I maintain that if this breaks the 50p barrier it will then plummet rapidly like many of the other super ramped stocks recommended by PURCHASE. The only hope will then be for a takeover well below 80p IMO. AN had such an amazing product here but clearly didn’t know how to market it.
antonagis
Chat Pages: Latest  808  807  806  805  804  803  802  801  800  799  798  797  Older

Your Recent History

Delayed Upgrade Clock